Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03550170 · ClinicalTrials.gov registry record · NA

Fatigue Management Programs for People With MS

A NA study, sponsored by Case Western Reserve University.

Completed
Registry status
NA
Development phase
590
Enrollment target

NCT03550170: Completed NA study, sponsored by Case Western Reserve University.

NCT03550170 is a NA study that has completed, run by Case Western Reserve University. The registered enrollment target is 590 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03550170, a NA study, has completed, sponsored by Case Western Reserve University.

COMPLETED
Registry status
NA
Development phase
590 participants
Enrollment target

Study Summary

This is a multi-site randomized clinical trial comparing 3 modes of delivering the Managing Fatigue course for reducing fatigue in individuals with multiple sclerosis (MS). The primary hypothesis is that the teleconference and internet versions of the course will be noninferior to the one-on-one, in person version in terms of the primary outcome of fatigue and secondary outcome of quality of life.

Primary Outcome

Fatigue will be assessed with Fatigue Impact Scale. Fatigue Impact Scale is a 40-item questionnaire that measures impact of fatigue on day-to-day life. Scale ranges from "no problem" (0) to "extreme problem" (4). Total scores will be computed by summing responses for each item. Scores can range from 0 to 160 with a higher score indicating worse fatigue.

Interventions

  • BEHAVIORAL Teleconference
  • BEHAVIORAL Internet
  • BEHAVIORAL 1-to-1, in-person or videoconference

Trial Details

FieldValue
Enrollment Target 590 participants
Start Date 2019-03-01
Est. Completion 2023-04-28
Phase NA
Case Western Reserve University

141 total trials

What the finished NCT03550170 record still lists

NCT03550170 is an interventional study that assigns participants to a tested intervention. The registered 590 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower).

The record links to 0 conditions, and to 3 interventions - of which Teleconference is the first listed.

NCT03550170 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03550170 about?

NCT03550170 is a clinical study titled "Fatigue Management Programs for People With MS". This is a multi-site randomized clinical trial comparing 3 modes of delivering the Managing Fatigue course for reducing fatigue in individuals with multiple sclerosis (MS). The primary hypothesis is that the teleconference and internet versions of the course will be noninferior to the one-on-one, in...

What is the current status of trial NCT03550170?

This trial is currently completed. It is a NA study. The enrollment target is 590 participants. The study started on 2019-03-01. Estimated completion is 2023-04-28.

What interventions are being tested in trial NCT03550170?

The interventions under investigation include: Teleconference (BEHAVIORAL), Internet (BEHAVIORAL), 1-to-1, in-person or videoconference (BEHAVIORAL).

Who is sponsoring clinical trial NCT03550170?

This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03550170's enrollment target sits among peer trials

590 175th of 2000 higher than 1,825 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01365169 · 590 participants · NA

    Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

  • NCT03774758 · 590 participants

    Biomarkers for Risk Stratification in Lung Cancer

  • NCT04747626 · 590 participants · NA

    B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair

  • NCT05722938 · 590 participants · Phase 3

    Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03550170, the US trial registry maintained by the National Library of Medicine. NCT03550170 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.